Back to search
Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of this study is to assess the long-term safety, including pregnancy, infant, and lactation outcomes, of patients with LC-FAOD who are enr…
Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.
The main goal of this study is to evaluate the effects of triheptanoin versus Medium-chain Triglycerides (MCT) on frequency of Major Clinical Events (MCEs).